327 related articles for article (PubMed ID: 31329924)
21. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
22. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
23. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
24. A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi.
Zhang R; Ran Y; Zhang H; Dai Y; Ran X; Zhang C; Qin W; Xi L
Mycopathologia; 2019 Apr; 184(2):349-352. PubMed ID: 30701405
[No Abstract] [Full Text] [Related]
25. Molecular epidemiology of Fonsecaea species.
Najafzadeh MJ; Sun J; Vicente VA; Klaassen CH; Bonifaz A; Gerrits van den Ende AH; Menken SB; de Hoog GS
Emerg Infect Dis; 2011 Mar; 17(3):464-9. PubMed ID: 21392438
[TBL] [Abstract][Full Text] [Related]
26. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.
He L; Ma J; Mei X; Lu S; Li X; Xi L
Mycoses; 2018 Apr; 61(4):231-236. PubMed ID: 29178398
[TBL] [Abstract][Full Text] [Related]
32. Identification of chromoblastomycosis agents by PCR based reverse line blot (PCR-RLB) hybridization assay.
Najafzadeh MJ; Gerrits van den Ende AHG; Vicente VA; Dolatabadi S; Sun J; de Hoog GS
Microb Pathog; 2018 Dec; 125():43-47. PubMed ID: 30194974
[TBL] [Abstract][Full Text] [Related]
33. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Yu J; Li R; Zhang M; Liu L; Wan Z
Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
[TBL] [Abstract][Full Text] [Related]
34. New methylene blue-mediated photodynamic inactivation of multidrug-resistant Fonsecaea nubica infected chromoblastomycosis in vitro.
Zheng M; Zhou X; Pang J; Yang Z; Zou Y; Zhang L; Xu Y; Yin R
Braz J Microbiol; 2023 Jun; 54(2):873-883. PubMed ID: 37145297
[TBL] [Abstract][Full Text] [Related]
35. Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole.
Cardona-Castro N; Agudelo-Flórez P; Restrepo-Molina R
Mem Inst Oswaldo Cruz; 1996; 91(6):779-84. PubMed ID: 9283666
[TBL] [Abstract][Full Text] [Related]
36. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
Gupta AK; Taborda PR; Sanzovo AD
Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
[TBL] [Abstract][Full Text] [Related]
37. Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.
Heidrich D; Pagani DM; Koehler A; Alves KO; Scroferneker ML
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0054621. PubMed ID: 33972246
[TBL] [Abstract][Full Text] [Related]
38. Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.
Mouchalouat Mde F; Gutierrez Galhardo MC; Zancopé-Oliveira RM; Monteiro Fialho PC; de Oliveira Coelho JM; Silva Tavares PM; Francesconi do Valle AC
Int J Dermatol; 2011 Aug; 50(8):981-6. PubMed ID: 21781072
[TBL] [Abstract][Full Text] [Related]
39. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.
Xi L; Sun J; Lu C; Liu H; Xie Z; Fukushima K; Takizawa K; Najafzadeh MJ; De Hoog GS
Med Mycol; 2009 Feb; 47(1):27-33. PubMed ID: 18951291
[TBL] [Abstract][Full Text] [Related]
40. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
